Jasjit S. Ahluwalia, MD, MPH
Professor of Medicine
University of North Carolina, Chapel Hill
Harvard Medical School, Clinical Epidemiology
New York University
Public Health, Tulane University
P: (612) 626-3378
F: (612) 626-6782
Division of General Internal Medicine
717 Delaware Street SE, Suite 166
Minneapolis, MN 55414
Executive Director, Center for Health Equity
Associate Director, Clinical and Translational Sciences Institute (CTSI)
Director, Research Education, Training and Career Development
Dr. Jas Ahluwalia has devoted the past 21 years to improving the health of high risk populations, and is known nationally for his work with the underserved and ethnic minorities. He joined the faculty at Emory University and in 1997, joined the University of Kansas where he was the Sosland Family Professor and Chair of the Department of Preventive Medicine and Public Health. In September 2005, Dr. Ahluwalia joined the University of Minnesota Academic Health Center as the founding Executive Director for the Office of Clinical Research. In summer 2009, he received the NIH P60 Comprehensive Centers of Excellence in Health Disparities and Minority Health. This $6.2 million grant established the Center for Health Equity for which he serves as the founding Executive Director. Dr. Ahluwalia also continues his NIH-funded research and is currently senior scientist on three NIH R01s grants and is mentoring six faculty members and a postdoctoral fellow. Dr. Ahluwalia is also an Associate Director for the Clinical and Translational Sciences Institute (CTSI) where he leads clinical research education, training and career development for the CTSI. Dr. Ahluwalia has published over 250 papers and has received $21 million in funding as a principal investigator and over $80 million as a co-investigator, largely from the NIH. He received the 2009 Herbert W. Nickens award for national leadership and research in improving minority health and mentoring of ethnic minority investigators. In 2010, he accepted the national Joe Cullen Award for Tobacco Research from the American Society for Preventive Oncology (ASPO), and in 2011, the Lifetime Leadership Award from the APHA for his work on tobacco. He served as the inaugural chair of a newly charted NIH study section titled, Health Disparities and Equity Promotion, and is the Chair of the NIH National Advisory Council for the National Institute of Minority Health and Health Disparities.
Honors, Awards, Organizations
- Principal Investigator, National Institute for Health Center of Excellence P60 grant, University of Minnesota Center for Health Equity
- 2012 Prevent Cancer Foundation - Prevention Laurel for National Leadership
- 2011 APHA (ATOD Section) Lifetime Achievement Award for tobacco research
- 2010 American Society for Preventive Oncology (ASPO) Cullen award for tobacco research
- Herbert W. Nickens Award, Society of General Internal Medicine, 2009
- F. Marian Bishop Educator of the Year award, Association of Teachers of Preventive Medicine (ATPM), 2003
- Recipient, Annual Kemper Foundation Teaching Excellence Award (the University of Kansas’ highest teaching award with a $5,000 stipend); 2002.
- Recipient, on behalf of the University of Kansas School of Medicine, Department of Preventive Medicine, the ATPM Outstanding Educational Program of the Year Award (recognizes an innovative program, department or academic institution for advancing undergraduate or graduate medical education in preventive medicine and public health); 2001
- 2001 Inaugural Society of Behavioral Medicine Annual Mentor of the Year Award. Presented in Washington DC; 2001
- 2000 Annual University of Kansas Medical Center Researcher of the Year Investigator Award; 2000
- Fellow, The Society of Behavioral Medicine (SBM); 2000
- Robert Wood Johnson Foundation Generalist Physicians Faculty Scholar; 1997 - 2001
Ongoing Research Support
- U54 RR026066-01A2 Blazar, Bruce (PI) 6/1/11 – 4/30/16
National Center for Research Resources (NCCR/NIH)
University of Minnesota Clinical and Translational Science Institute(CTSI)
Institutional award to enhance clinical and translational research at the University of Minnesota. Dr. Ahluwalia serves as Associate Director, and leads Clinical Research Training, Education, and Career Development.
Role: Associate Director and Co-Investigator
- U54MD008620-01 (Vickers) 7/01/2013 – 6/30/2018
National Institute for Minority Health and health Disparities (NIMHD)
National Transdisciplinary Collaborative Center for African American Men’s Health
This national center will address health disparities in conditions affecting African American men targeting disparities in unintentional and violence-related injuries and chronic diseases across the life course. The cores include research, outreach, training and diffusion.
Role: Co-I (Diffusion Core)
- 1P60MD003422-01 – Ahluwalia (PI) 7/27/09 – 5/30/14
National Center for Minority Health Disparities (NIMHD)
University of Minnesota Center for Health Equity (CHE) - This Center of Excellence will be comprised of four Cores: Administrative, Research, Research Training and Education, and Community Engagement and Outreach, and one research project.
- Collins (PI) 7/1/10 - 6/30/14
National Heart, Lung, Blood Institute
Promoting Walking in African Americans with Peripheral Arterial Disease
To determine efficacy of our PACE protocol in 204 participants randomized participants to one of three study arms: 1) Attention Control (Tx1); 2) PACE alone (Tx2); or 3) PACE Plus (Tx3).
Role: Principal Investigator for subcontract
- U24 MD006970 - Vickers (PI) 9/19/11 – 5/31/16
National Center for Minority Health Disparities (NCMHD/NIH)
Enhancing Minority Participation in Clinical Trials (EMPaCT II) Phase II
Consortium to increase recruitment and retention of minorities into therapeutic clinical trials.
- 1P60MD003422-01 - Thomas (Project PI) 7/27/09 – 5/30/14
National Center for Minority Health Disparities
Project: Community Outreach and Biomarker Feedback to Promote Smoke-Free Somali Homes
A randomized intervention trial that will employ Community Health Workers and state-of-the-art biomarker feedback to encourage cessation and home smoking restriction among African American families.
Role: Co-Principal Investigator
- 1R01HL094183 – Thomas (PI) 4/10/09 - 3/31/14
National Heart, Lung, Blood Institute
Enhancing Quit and Win contests to Improve Cessation among College Smokers
Evaluate efficacy of two theory-based approaches to enhance maintenance of abstinence amongst participants 1) extended financial incentives and/or 2) Motivational Relapse Prevention counseling to increase quitting.
Role: Co-Principal Investigator
- Ahluwalia (PI) 11/1/11 – 11/1/13
Pfizer GRAND Program - Factors Influencing Nondaily Cigarette Smoking and Cessation
Conduct nine focus groups to: (Aim 1) and to (Aim 2) conduct an online survey of 2,400 triethnic smokers.
- R01 DA031815-01 – Nollen (PI) 7/1/11 - 6/30/16
National Institute of Drug Abuse
Understanding Disparities in Quitting in African American and White Smokers
Examine varenicline for smoking cessation among AA and White smokers.
Role: Co-PI - Jasjit S. Ahluwalia, M.D., M.P.H., M.S.
- Berg CJ, Wen H, Cummings JR, Ahluwalia JS, Druss BG. Depression and Substance Abuse and Dependency in Relation to Current Smoking Status and Frequency of Smoking Among Nondaily and Daily Smokers. American Journal on Addictions; 2013; 28(2): 313-25.
- Okuyemi KS, Goldade K, Whembolua GL, Thomas JL, Eischen S, Guo H, Connett JE, Grant J, Ahluwalia JS, Resnicow K, Owen G, Gelberg L, Des Jarlais D. Motivational Interviewing to Enhance Nicotine Patch Treatment for Smoking Cessation among Homeless Smokers: A Randomized Controlled Trial. Addiction; 2013; 108(6):1136-44.
- Pulvers K, Bachand J, Nollen N, Guo H, Ahluwalia JS. BMI-based Norms for a Culturally Relevant Body Image Scale among African Americans. Eating Behaviors; 2013; 14: 437-480.
- Liao W, Luo X, Le C, Chu H, Epstein LH, Yu J, Ahluwalia JS, Thomas J. Analysis of cigarette purchase task instrument data with a left-censored mixed effects model. Experimental and Clinical Psychopharmacology; 2013; 21(2):124-132. PMID:23356731
- Buchanan TS, Cox LS, Thomas JL, Nollen NL, Berg CJ, Mayo MS, Ahluwalia JS. Perceived Treatment Assignment and Smoking Cessation in a Clinical Trial of Bupropion Versus Placebo. Nicotine & Tobacco Research; 2013; 15(2):567-571.
- Cox LS, Nollen NL, Mayo MS, Choi WS, Faseru BF, Benowitz NL, Tyndale RF, Okuyemi KS, Ahluwalia JS. Bupropion for Smoking Cessation in African American Light Smokers: A Randomized Controlled Trial. Journal of the National Cancer Institute. 2012; 104(4):1-9.
- Zhu AZX, Cox LS, Nollen N, Faseru B, Okuyemi KS, Ahluwalia JS, Benowitz NL, Tyndale RF. CYP2B6 and Bupropion’s Smoking Cessation Pharmacology: The Role of Hydroxybupropion. Clinical Pharmacology and Therapeutics; 2012; 92(6): 771-7.
- Ahluwalia JS, Okuyemi K, Nollen N, Choi WS, Kaur H, Pulvers K, Mayo MS. The Effects of Nicotine Gum and Counseling Among African American Light Smokers: A 2x2 Factorial Design. Addiction; 2006:101:883-891
- Ahluwalia JS, Nollen N, Kaur H, James AJ, Mayo M, Resnicow K. Pathways to Health: Cluster-Randomized Trial to Increase Fruit and Vegetable Consumption among Smokers in Public Housing. Health Psych. 2006:26:214-221.
- Ahluwalia JS, Harris KJ. Catley D, Okuyemi K, Mayo MS. A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation in African Americans. JAMA; 2002; 288:468-474.